- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-26-0141846

About Premium Serums and Vaccines Private Limited
Data last updated:
Premium Serums and Vaccines Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 January 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2009PTC189968. Its GSTIN is 27AAFCP0651A1ZX (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Shyam Bhalchandra Dhawan and Girish Nathuram Kolwankar.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 406 B Wing Highway Rose Co – Op Hsg Society 92 Dixit Road Extn. Vile Parle (East), Mumbai, Maharashtra, India – 400057.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.25 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹9.64 Cr (net margin 14.3%) and EBITDA of ₹17.83 Cr (EBITDA margin 26.5%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 23% over five years.
The company has about 112 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Premium Serums and Vaccines. As per MCA filings, the company has open charges of ₹75.1 Cr on record. Court records list 8 cases involving the company, including 4 filed by the company and 4 filed against it; 1 case is pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹1.99 Cr; the latest was in March 2011. Its 5 peer companies in the Pharma industry (Formulations, Vaccines), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Beloorbayir Biotech Limited with revenue of ₹67.42 Cr.
Premium Serums and Vaccines Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0141846). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website premiumserums.com.
Company details
Recognitions & Rankings of Premium Serums and Vaccines
Contact details
Premium Serums and Vaccines Private Limited's registered office is in Mumbai, Maharashtra. Its website is premiumserums.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address406 B Wing Highway Rose Co – Op Hsg Society 92 Dixit Road Extn. Vile Parle (East), Mumbai, Maharashtra, India – 400057
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Premium Serums and Vaccines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Premium Serums and Vaccines operates one associated brand: Premium Serums and Vaccines. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of biological products, including equine immunoglobulins and antivenoms, for healthcare applications. | premiumserums.com |
Business activity
The main business activity of Premium Serums and Vaccines is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Premium Serums and Vaccines Private Limited, buy the company report.
Financials of Premium Serums and Vaccines Private Limited
FY 2025 filings availablePremium Serums and Vaccines Private Limited reported revenue of ₹67.25 Cr (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 28% growth in the latest year. EBITDA rose 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.83 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.64 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.5% | ||||
| Net Profit Margin | 14.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Premium Serums and Vaccines Private Limited, buy the company report.
Board of directors of Premium Serums and Vaccines Private Limited
Premium Serums and Vaccines has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shyam Bhalchandra Dhawan | Director | 29 Jan 2009 | 17 Years 9 Months | Current |
| Girish Nathuram Kolwankar Also directs: Premium Agro Industries P.Ltd., Stellar Petfood Private Limited, Alpha Feeds Private Limited and 1 more | Director | 29 Jan 2009 | 17 Years 9 Months | Current |
Peer comparison
Premium Serums and Vaccines Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Vaccines), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Beloorbayir Biotech Limited | ₹67.42 Cr (FY 2021) | -4.0% | Bangalore, Karnataka, India | |||
| United Bioceuticals Private Limited | ₹67.35 Cr (FY 2024) | 31.0% | New Delhi, Delhi, India | |||
| Samson Laboratories Private Limited | ₹67.3 Cr (FY 2025) | 13.0% | Delhi, India | |||
| Premium Serums and Vaccines Private Limitedthis company | ₹67.25 Cr (FY 2025) | ₹9.64 Cr | 14.3% | 28.0% | 112 | Mumbai, Maharashtra, India |
| Pharmax India Private Limited | ₹66.65 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Merril Pharma Private Limited | ₹66.57 Cr (FY 2025) | 25.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Premium Serums and Vaccines Private Limited, buy the company report.
Auditor
Premium Serums and Vaccines Private Limited is audited by TEMBEY & MHATRE for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TEMBEY & MHATRE | FY 2023 | 116359W |
Shareholding
The shareholding of Premium Serums and Vaccines Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Premium Serums and Vaccines Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2025 | 101081774 | Others | ₹3 Cr | Open | |
| 25 Mar 2025 | 101080971 | Others | ₹10.67 Cr | Open | |
| 16 Dec 2023 | 100840859 | Others | ₹26 Lakh | Open | |
| 13 Dec 2023 | 100840858 | Others | ₹4.6 Cr | Open | |
| 09 May 2023 | 100736693 | Others | ₹10 Lakh | Open |
To see the full charge records of Premium Serums and Vaccines Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Premium Serums and Vaccines Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹1.99 Cr; the latest was in March 2011.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2011 | Funding round | ₹1.99 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Premium Serums and Vaccines Private Limited has 8 court cases on record: 4 filed by Premium Serums and Vaccines, 4 filed against it. 1 case is pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 4 | 1 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Court case (T.P. CRL) | Filed against the company by M/S Vins Bioproducts Ltd. | Disposed |
| District court, South, Delhi | Revision petition | Filed against the company by M/S Vins Bioproducts Ltd. | Disposed |
| District court, South, Delhi | Criminal case | Filed by the company against M/S Vins Bioproducts Ltd and Ors | Disposed |
| District court, Sangli, Maharashtra | Civil suit | Filed against the company by an individual | Pending |
| District court, Lucknow, Uttar Pradesh | Civil suit | Filed against the company by M/S Eastern Medical and Surgical Corporation | Disposed |
To see the full case history of Premium Serums and Vaccines Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Premium Serums and Vaccines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Premium Serums and Vaccines Private Limited has a workforce of 112 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 112 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Premium Serums and Vaccines Private Limited, buy the company report.
GST
Premium Serums and Vaccines has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCP0651A1ZX | Maharashtra | Active | 01 Jul 2017 |
| 36AAFCP0651A1ZY | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Premium Serums and Vaccines Private Limited, buy the company report.
Recent activity
Premium Serums and Vaccines Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Girish Nathuram Kolwankar was appointed as Director on 29 Jan 2009.
6 earlier events are in the company report.
Frequently asked questions
Premium Serums and Vaccines is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 January 2009 (17+ years old) and is registered under CIN U24110MH2009PTC189968.
Premium Serums and Vaccines has 2 current directors:
- Shyam Bhalchandra Dhawan - Director
- Girish Nathuram Kolwankar - Director
The latest financial statements of Premium Serums and Vaccines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Premium Serums and Vaccines is 27AAFCP0651A1ZX, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAFCP0651A1ZY (Telangana).
The CIN (Corporate Identification Number) of Premium Serums and Vaccines is U24110MH2009PTC189968. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Premium Serums and Vaccines has 8 court cases on record: 4 filed by the company and 4 filed against it. 1 is pending. Most are in the district courts.
Premium Serums and Vaccines was incorporated on 29 January 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Premium Serums and Vaccines has 1 deal on record (1 funding round), with disclosed funding of ₹1.99 Cr; the latest was in March 2011.
The peers of Premium Serums and Vaccines by revenue are Beloorbayir Biotech Limited, United Bioceuticals Private Limited, Samson Laboratories Private Limited, Pharmax India Private Limited, Merril Pharma Private Limited, all in the Pharma industry (Formulations, Vaccines), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Girish Nathuram Kolwankar was appointed as Director on 29 Jan 2009. Shyam Bhalchandra Dhawan was appointed as Director on 29 Jan 2009.
Yes, Premium Serums and Vaccines is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-26-0141846).

